Research study Program year 2023 Source: CMS Open Payments

CatC inhibitor Phase II in non CF bronchiectasis

Research payments

$615,988

42 payments

Through program year 2023, $615,988 in research payments was reported against CatC inhibitor Phase II in non CF bronchiectasis, across 42 payments.

Paid by (largest first)
Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim Pharma GmbH & Co.KG
ClinicalTrials.gov
No trial number was reported for this study

By program year

2 rows
Year Kind Amount Payments
2023 Research $458,053 22
2022 Research $157,935 20

Breakdown

Who paid Research payments · program years 2022–2023
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $497,516 28 payments
  2. Boehringer Ingelheim Pharma GmbH & Co.KG $118,472 14 payments
Who received the money Research payments · program years 2022–2023
  1. Uc Davis Medical Center Teaching hospital · CA $151,649 1 payment
  2. University Of Kansas Medical Center Organisation paid for research $94,622 6 payments
  3. Medical University of South Carolina Organisation paid for research $90,255 5 payments
  4. University of Cincinnati Organisation paid for research $70,343 6 payments
  5. Fort Worth Medtex Pllc Organisation paid for research $64,372 2 payments
  6. North Florida Foundation For Research Organisation paid for research $63,426 2 payments
  7. Southeastern Research Center Organisation paid for research $32,565 6 payments
  8. Diagnostics Research Group Organisation paid for research $21,876 4 payments
  9. Malcom Randall Department Of Veterans Affairs Medical Center-Hematology Oncology Organisation paid for research $14,665 4 payments
  10. University Of California Davis Organisation paid for research $8,550 4 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

7 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record